View Item 

Show simple item record

Proceedings From FDA/A.S.P.E.N. Public Workshop
dc.contributor.authorTeitelbaum, Daniel H.
dc.contributor.authorGuenter, Peggi
dc.contributor.authorGriebel, Donna
dc.contributor.authorAbrams, Steven A.
dc.contributor.authorBark, Staffan
dc.contributor.authorBaker, Mary
dc.contributor.authorBerry, Karyn L.
dc.contributor.authorBistrian, Bruce R.
dc.contributor.authorBrenna, J. Thomas
dc.contributor.authorBonnot, Denis
dc.contributor.authorCarpentier, Yvon A.
dc.contributor.authorDeckelbaum, Richard J.
dc.contributor.authorHise, Mary
dc.contributor.authorKoletzko, Berthold
dc.contributor.authorMirtallo, Jay M.
dc.contributor.authorMulberg, Andrew E.
dc.contributor.authorO’Reilly, Randall C.
dc.contributor.authorShaffer, Jonathan
dc.contributor.authorKleist, Elke
dc.contributor.authorZaloga, Gary P.
dc.contributor.authorZiegler, Thomas R.
dc.date.accessioned2018-02-05T16:28:21Z
dc.date.available2018-02-05T16:28:21Z
dc.date.issued2015-09
dc.identifier.citationTeitelbaum, Daniel H.; Guenter, Peggi; Griebel, Donna; Abrams, Steven A.; Bark, Staffan; Baker, Mary; Berry, Karyn L.; Bistrian, Bruce R.; Brenna, J. Thomas; Bonnot, Denis; Carpentier, Yvon A.; Deckelbaum, Richard J.; Hise, Mary; Koletzko, Berthold; Mirtallo, Jay M.; Mulberg, Andrew E.; O’Reilly, Randall C.; Shaffer, Jonathan; Kleist, Elke; Zaloga, Gary P.; Ziegler, Thomas R. (2015). "Proceedings From FDA/A.S.P.E.N. Public Workshop." Journal of Parenteral and Enteral Nutrition 39(7): 768-786.
dc.identifier.issn0148-6071
dc.identifier.issn1941-2444
dc.identifier.urihttps://hdl.handle.net/2027.42/141152
dc.publisherWiley Periodicals, Inc.
dc.publisherSAGE Publications
dc.subject.otherfatty acids
dc.subject.otherresearch and diseases
dc.subject.otherlipids
dc.subject.othernutrition
dc.titleProceedings From FDA/A.S.P.E.N. Public Workshop
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPediatrics
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumC.S. Mott Children’s Hospital, University of Michigan, Ann Arbor, Michigan
dc.contributor.affiliationotherDivision of Gastroenterology and Inborn Error Products, Office of Drug Evaluation III, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland
dc.contributor.affiliationotherDivision of Endocrinology, Metabolism and Lipids and Emory Center for Clinical and Molecular Nutrition, Emory University Hospital, Atlanta, Georgia
dc.contributor.affiliationotherHospital Care Division, B. Braun Melsungen AG, Melsungen, Germany
dc.contributor.affiliationotherIntestinal Failure Unit, Salford Royal Hospital, University of Manchester, United Kingdom
dc.contributor.affiliationotherUniversity of Colorado, Boulder, Colorado
dc.contributor.affiliationotherThe Ohio State University, College of Pharmacy, Ohio State University, Columbus, Ohio
dc.contributor.affiliationotherDr von Hauner Children’s Hospital, University of Munich Medical Centre, Germany
dc.contributor.affiliationotherBaxter Healthcare, Deerfield, Illinois
dc.contributor.affiliationotherDepartment of Pediatrics and Epidemiology, Institute of Human Nutrition, Columbia University Medical Center, New York, New York
dc.contributor.affiliationotherFree University of Brussels (Université Libre de Bruxelles) and Lipid Nutrition Center, Brussels, Belgium
dc.contributor.affiliationotherAmerican Society for Parenteral and Enteral Nutrition, Silver Spring, Maryland
dc.contributor.affiliationotherScientific Affairs, Business Unit, Parenteral Nutrition & Colloids, Fresenius Kabi Deutschland GmbH, Bad Homburg, Germany
dc.contributor.affiliationotherDivision of Nutritional Sciences, Cornell University, Ithaca, New York
dc.contributor.affiliationotherHarvard Medical School, Clinical Nutrition, Beth Israel Deaconess Medical Center, Boston, Massachusetts
dc.contributor.affiliationotherHospira, Inc, Chicago, Illinois
dc.contributor.affiliationotherDepartment of Surgery, Karolinska Institute, Stockholm, Sweden, and Department of Surgery, Visby Hospital, Visby, Sweden
dc.contributor.affiliationotherDepartment of Pediatrics, Sections of Neonatology and USDA/ARS Children’s Nutrition Research Center, Baylor College of Medicine and Texas Children’s Hospital, Houston, Texas
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141152/1/jpen0768.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141152/2/jpen0768-sup-0001.pdf
dc.identifier.doi10.1177/0148607114560825
dc.identifier.sourceJournal of Parenteral and Enteral Nutrition
dc.identifier.citedreferenceUmpierrez GE, Spiegelman R, Zhao V et al. A double‐blind, randomized clinical trial comparing soybean oil‐based versus olive oil‐based lipid emulsions in adult medical‐surgical ICU patients requiring parenteral nutrition. Crit Care Med. 2012; 40 ( 6 ): 1792 ‐ 1798.
dc.identifier.citedreferencePalmer AJ, Ho CK, Ajibola O, Avenell A. The role of ω‐3 fatty acid supplemented parenteral nutrition in critical illness in adults: a systematic review and meta‐analysis. Crit Care Med. 2013; 41: 307 ‐ 316.
dc.identifier.citedreferenceChen B, Zhou Y, Yang P, Wan HW, Wu XT. Safety and efficacy of fish oil‐enriched parenteral nutrition regimen on postoperative patients undergoing major abdominal surgery: a meta‐analysis of randomized controlled trials. JPEN J Parenter Enteral Nutr. 2010; 34 ( 4 ): 387 ‐ 394.
dc.identifier.citedreferencePontes‐Arruda A, Demichele S, Seth A, Singer P. The use of an inflammation‐modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta‐analysis of outcome data. JPEN J Parenter Enteral Nutr. 2008; 32 ( 6 ): 595 ‐ 605.
dc.identifier.citedreferenceRice TW, Wheeler AP, Thompson BT, deBoisblanc BP, Steingrub J, Rock P; HIH NHLBI Acute Respiratory Distress Syndrome Network of Investigators. Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA. 2011; 306 ( 14 ): 1574 ‐ 1581.
dc.identifier.citedreferenceBistrian BR. Supplementation in acute lung injury. JAMA. 2012; 307 ( 2 ): 144 ‐ 145.
dc.identifier.citedreferencePickkers P, de Keizer N, Dusseljee J, Weerheijm D, van der Hoever JG, Peek N. Body mass index is associated with hospital mortality in critically ill patients: an observational cohort study. Crit Care Med. 2013; 41 ( 8 ): 1878 ‐ 1883.
dc.identifier.citedreferenceBistrian BR. Is total parenteral nutrition protective against hypoglycemia during intensive insulin therapy? A hypothesis. Crit Care Med. 2011; 39 ( 6 ): 1533 ‐ 1535.
dc.identifier.citedreferenceBistrian BR. What is early and adequate feeding? Crit Care Med. 2012; 40 ( 1 ): 307 ‐ 308.
dc.identifier.citedreferenceKlein S, Miles JM. Metabolic effects of long‐chain and medium‐chain triglyceride emulsions in humans. JPEN J Parenter Enteral Nutr. 1994; 18 ( 5 ): 396 ‐ 397.
dc.identifier.citedreferenceSimoens CM, Deckelbaum RJ, Massaut JJ, Carpentier YA. Inclusion of 10% fish oil in mixed medium‐chain triacylglycerol‐long‐chain triacylglycerol emulsions increases plasma triacylglycerol clearance and induces rapid eicosapentaenoic acid (20:5) incorporation into blood cell phospholipids. Am J Clin Nutr. 2008; 88 ( 2 ): 282 ‐ 288.
dc.identifier.citedreferenceBrouwer CB, de Bruin TW, Jansen H, Erkelens DW. Different clearance of intravenously administered olive oil and soybean‐oil emulsions: role of hepatic lipase. Am J Clin Nutr. 1993; 57 ( 4 ): 533 ‐ 539.
dc.identifier.citedreferenceCalder PC. Lipids for intravenous nutrition in hospitalised adult patients: a multiple choice of options. Proc Nutr Soc. 2013; 72 ( 3 ): 263 ‐ 276.
dc.identifier.citedreferenceEdmunds CE, Brody RA, Parrott JS, Stankorb SM, Heyland DK. The effects of different IV fat emulsions on clinical outcomes in critically ill patients. Crit Care Med. 2014; 42 ( 5 ): 1168 ‐ 1177.
dc.identifier.citedreferenceFDA approves Clinolipid for intravenous nutrition. Silver Spring, MD: US Food and Drug Administration, US Department of Health and Human Services; Press release, October 3, 2013. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm370740.htm. Accessed October 22, 2013.
dc.identifier.citedreferenceGoldberg R, Gore JM, Barton B, Gurwitz J. Individual and composite study endpoints: separating the wheat from the chaff. Am J Med. 2014; 127 ( 5 ): 379 ‐ 384.
dc.identifier.citedreferenceKalish BT, Le HD, Gura KM, Bistrian BR, Puder M. A metabolomic analysis of two intravenous lipid emulsions in a murine model. PLoS One. 2013; 8 ( 4 ): e59653.
dc.identifier.citedreferenceKlek S, Chambrier C, Singer P et al. Four‐week parenteral nutrition using a third generation lipid emulsion (SMOFlipid)—a double‐blind, randomised, multicentre study in adults. Clin Nutr. 2013; 32 ( 2 ): 224 ‐ 231.
dc.identifier.citedreferenceLe HD, de Meijer VE, Robinson EM et al. Parenteral fish‐oil‐based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition‐dependent children. Am J Clin Nutr. 2011; 94 ( 3 ): 749 ‐ 758.
dc.identifier.citedreferenceLook AHEAD Research Group, Wing RR, Bolin P et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2014; 369 ( 2 ): 145 ‐ 154.
dc.identifier.citedreferenceMa CJ, Sun LC, Chen FM et al. A double‐blind randomized study comparing the efficacy and safety of a composite vs a conventional intravenous fat emulsion in postsurgical gastrointestinal tumor patients. Nutr Clin Pract. 2012; 27 ( 3 ): 410 ‐ 415.
dc.identifier.citedreferenceManzanares W, Dhaliwal R, Jurewitsch B, Stapleton RD, Jeejeebhoy KN, Heyland DK. Alternative lipid emulsions in the critically ill: a systematic review of the evidence. Intensive Care Med. 2013; 39 ( 10 ): 1683 ‐ 1694.
dc.identifier.citedreferenceUnnikrishnan AG, Bhattacharyya A, Baruah MP, Sinha B, Dharmalingam M, Rao PV. Importance of achieving the composite endpoints in diabetes. Ind J Endocrinol Metab. 2013; 17 ( 5 ): 835 ‐ 843.
dc.identifier.citedreferenceVenecourt‐Jackson E, Hill SJ, Walmsley RS. Successful treatment of parenteral nutrition‐associated liver disease in an adult by use of a fish oil‐based lipid source. Nutrition. 2013; 29 ( 1 ): 356 ‐ 358.
dc.identifier.citedreferenceZiegler TR. Nutrition support in critical illness—bridging the evidence gap. N Engl J Med. 2011; 365: 562 ‐ 564.
dc.identifier.citedreferenceDriscoll DF. Lipid injectable emulsions. Nutr Clin Pract. 2006; 21: 381 ‐ 386.
dc.identifier.citedreferenceHardy G, Puzovic M. Formulation, stability, and administration of parenteral nutrition with new lipid emulsions. Nutr Clin Pract. 2009; 24: 616 ‐ 625.
dc.identifier.citedreferenceHicks RW, Becker SC, Chuo J. A summary of NICU fat emulsion medication errors and nursing services. Adv Neonat Care. 2007; 7: 299 ‐ 310.
dc.identifier.citedreferenceGura KM, Parsons SK, Bechard LJ et al. Use of fish oil‐based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr 2005; 24: 839 ‐ 847.
dc.identifier.citedreferenceGura KM, Puder M. Rapid infusion of fish‐oil based emulsion in infants does not appear to be associated with fat overload syndrome. Nutr Clin Pract. 2010; 25: 399 ‐ 402.
dc.identifier.citedreferenceJurewitsch B, Gardiner G, Naccarato M, Jeejeebhoy KN. Omega‐3 enriched lipid emulsion for liver salvage in parenteral nutrition‐induced cholestasis in the adult patient. JPEN J Parenter Enter Nutr. 2011; 35: 386 ‐ 390.
dc.identifier.citedreferenceLlop JM, Virgili N, Moreno‐Villares JM et al. Phytosterolemia in parenteral nutrition patients: implications for liver disease development. Nutrition. 2008; 24: 1145 ‐ 1152.
dc.identifier.citedreferenceMirtallo JM, Dasta JF, Kleinschmidt KC, Varon J. State of the art review: intravenous fat emulsions: current applications, safety profile, and clinical implications. Ann Pharmacother. 2010; 44: 688 ‐ 700.
dc.identifier.citedreferenceSacks GS, Mouser JF. Is IV lipid emulsion safe in patients with hypertriglyceridemia? Nutr Clin Pract 1997; 12: 120 ‐ 123.
dc.identifier.citedreferenceSiqueira J, Smiley D, Newton C et al. Substitution of standard soybean oil with olive‐oil‐based lipid emulsion in parenteral nutrition: comparison of vascular, metabolic, and inflammatory effects. J Clin Endocrinol Metab. 2011; 96: 3207 ‐ 3216.
dc.identifier.citedreferenceSkouroliakou M, Konstantinou D, Agakidis C et al. Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT/ω‐3‐PUFA containing or soybean‐based lipid emulsions. Nutr Clin Pract. 2012; 27: 817 ‐ 822.
dc.identifier.citedreferenceXu Z, Yousheng L, Wang J, Wu B, Jieshou L. Effect of omega‐3 polyunsaturated fatty acids to reverse biopsy‐proven parenteral nutrition‐associated liver disease in adults. Clin Nutr. 2012; 31: 217 ‐ 223.
dc.identifier.citedreferenceThomasson HJ. Biological standardization of essential fatty acids; a new method. Int Z Vitaminforsch Beih. 1953; 25 ( 1 ): 62 ‐ 82.
dc.identifier.citedreferenceHansen AE, Haggard ME, Boelsche AN, Adam DJ, Wiese HF. Essential fatty acids in infant nutrition, III: clinical manifestations of linoleic acid deficiency. J Nutr. 1958; 66 ( 4 ): 565 ‐ 576.
dc.identifier.citedreferenceHansen AE, Wiese HF, Boelsche AN, Haggard ME, Adam DJ, Davis H. Role of linoleic acid in infant nutrition: clinical and chemical study of 428 infants fed on milk mixtures varying in kind and amount of fat. Pediatrics. 1963; 31 ( 1 ): 171 ‐ 192.
dc.identifier.citedreferenceWene JD, Connor WE, DenBesten L. The development of essential fatty acid deficiency in healthy men fed fat‐free diets intravenously and orally. J Clin Invest. 1975; 56 ( 1 ): 127 ‐ 134.
dc.identifier.citedreferenceCunnane SC, Anderson MJ. Pure linoleate deficiency in the rat: influence on growth, accumulation of n‐6 polyunsaturates, and [1‐14C]linoleate oxidation. J Lipid Res. 1997; 38 ( 4 ): 805 ‐ 812.
dc.identifier.citedreferenceBourre JM, Pascal G, Durand G, Masson M, Dumont O, Piciotti M. Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n‐3 fatty acids. J Neurochem. 1984; 43 ( 2 ): 342 ‐ 348.
dc.identifier.citedreferenceGibson RA, Neumann MA, Lien EL, Boyd KA, Tu WC. Docosahexaenoic acid synthesis from alpha‐linolenic acid is inhibited by diets high in polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2013; 88 ( 1 ): 139 ‐ 146.
dc.identifier.citedreferenceDiau GY, Hsieh AT, Sarkadi‐Nagy EA, Wijendran V, Nathanielsz PW, Brenna JT. The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Med. 2005; 3 ( 11 ): 11.
dc.identifier.citedreferenceKoletzko B, Agostoni C, Bergmann R, Ritzenthaler K, Shamir R. Physiological aspects of human milk lipids and implications for infant feeding: a workshop report. Acta Paediatr. 2011; 100 ( 11 ): 1405 ‐ 1415.
dc.identifier.citedreferenceKoletzko B, Goulet O. Fish oil containing intravenous lipid emulsions in parenteral nutrition‐associated cholestatic liver disease. Curr Opin Clin Nutr Metab Care. 2010; 13 ( 3 ): 321 ‐ 326.
dc.identifier.citedreferenceLehner F, Demmelmair H, Röschinger W et al. Metabolic effects of intravenous LCT or MCT/LCT lipid emulsions in preterm infants. J Lipid Res. 2006; 47 ( 2 ): 404 ‐ 411.
dc.identifier.citedreferenceMakrides M, Gibson RA, McPhee AJ et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomized controlled trial. JAMA. 2009; 301 ( 2 ): 175 ‐ 182.
dc.identifier.citedreferenceManley BJ, Makrides M, Collins CT et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics. 2011; 128 ( 1 ): e71 ‐ e77.
dc.identifier.citedreferenceManzanares W, Dhaliwal R, Jurewitsch B, Stapleton RD, Jeejeebhoy KN, Heyland DK. Alternative lipid emulsions in the critically ill: a systematic review of the evidence. Intensive Care Med. 2013; 39 ( 10 ): 1683 ‐ 1694.
dc.identifier.citedreferencePalmer AJ, Ho CK, Ajibola O, Avenell A. The role of ω‐3 fatty acid supplemented parenteral nutrition in critical illness in adults: a systematic review and meta‐analysis. Crit Care Med. 2013; 41 ( 1 ): 307 ‐ 316.
dc.identifier.citedreferencePuder M, Valim C, Meisel JA et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition‐associated liver injury. Ann Surg. 2009; 250 ( 3 ): 395 ‐ 402.
dc.identifier.citedreferenceRodriguez M, Funke S, Fink M et al. Plasma fatty acids and [13C]linoleic acid metabolism in preterm infants fed a formula with medium‐chain triglycerides. J Lipid Res. 2003; 44 ( 1 ): 41 ‐ 48.
dc.identifier.citedreferenceVlaardingerbroek H, Vermeulen MJ, Rook D et al. Safety and efficacy of early parenteral lipid and high‐dose amino acid administration to very low birth weight infants. J Pediatr. 2013; 163 ( 3 ): 638 ‐ 644.e1‐5.
dc.identifier.citedreferenceAbrams SA, Adams JM, Anderson DM et al. Guidelines for acute care of the neonate 21st edition, 2013‐2014. http://www.neonate.net/publications/physicians/#guidelines. Published April 2014. Accessed September 24, 2014.
dc.identifier.citedreferenceHowie S. Blood sample volumes in child health research: review of safe limits. Bull World Health Organ. 2011; 89: 46 ‐ 53.
dc.identifier.citedreferenceVanek VW, Seidner DL, Allen P et al. A.S.P.E.N. position paper: clinical role for alternative intravenous fat emulsions. Nutr Clin Pract. 2012; 27 ( 2 ): 150 ‐ 192.
dc.identifier.citedreferenceDudrick SJ, Wilmore DW, Vars HM, Rhoads JE. Parenteral Hyperalimentation. Philadelphia, PA: Department of Surgery and Harrison Department of Surgical Research, School of Medicine, University of Pennsylvania; 1968.
dc.identifier.citedreferenceDudrick SJ. The genesis of intravenous hyperalimentation. JPEN J Parenter Enteral Nutr. 1977; 1 ( 1 ): 23 ‐ 29.
dc.identifier.citedreferenceWretlind A. Development of fat emulsions. JPEN J Parenter Enteral Nutr. 1981; 5 ( 3 ): 230 ‐ 235.
dc.identifier.citedreferenceHoward L, Ament M, Fleming CR, Shike M, Steiger E. Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology. 1995; 109 ( 2 ): 355 ‐ 365.
dc.identifier.citedreferenceProgram of Technology and Health Care. Department of Community and Family Medicine, Georgetown University School of Medicine. Evaluating Total Parenteral Nutrition: Background Paper for a Technology Assessment and Practice Guidelines Forum. Washington, DC: Department of Health and Human Services; 1989.
dc.identifier.citedreferenceSteinberg EP, Anderson GF. Implications of Medicare’s prospective payment system for specialized nutrition services: the “Hopkins’ report.” Nutr Clin Pract. 1986; 1: 12 ‐ 28.
dc.identifier.citedreferenceAgency for Healthcare Research and Quality (AHRQ). National Inpatient Sample (NIS) of the Healthcare Cost and Utilization Project (HCUP) Web site. http://hcupnet.ahrq.gov/. Accessed June 26, 2013.
dc.identifier.citedreferenceTemple R. Are surrogate markers adequate to assess cardiovascular disease drugs? JAMA. 1999; 282 ( 8 ): 790 ‐ 795.
dc.identifier.citedreferenceUS Food and Drug Administration. CFR—Code of Federal Regulations Title 21. Fed Regist. 2006; 71: 3986.
dc.identifier.citedreferenceUS Food and Drug Administration. Guidance for industry postmarketing studies and clinical trials—implementation of section 505(o)(3) of the federal food, drug, and cosmetic act. Silver Spring, MD: US Department of Health and Human Services; 2011.
dc.identifier.citedreferenceUS Food and Drug Administration. Regulatory information: guidances web site. http://www.fda.gov/RegulatoryInformation/Guidances/default.htm. Accessed October 27, 2013.
dc.identifier.citedreferenceCalder PC, Deckelbaum RJ. Intravenous fish oil in hospitalized adult patients: reviewing the reviews. Curr Opin Clin Nutr Metab Care. 2013; 16 ( 2 ): 119 ‐ 123.
dc.identifier.citedreferenceDeckelbaum RJ, Hamilton J, Moser A et al. Medium chain vs. long chain triacylglycerol emulsion hydrolysis by lipoprotein lipase and hepatic lipase: implications for the mechanisms of lipase action. Biochemistry. 1990; 29 ( 5 ): 1136 ‐ 1142.
dc.identifier.citedreferenceHaumont D, Richelle M, Deckelbaum RJ, Coussaert E, Carpentier YA. Effects of liposomal content of lipid emulsions on plasma lipid concentrations in low birth weight infants receiving parenteral nutrition. J Pediatr. 1992; 121 ( 5 pt 1 ): 759 ‐ 763.
dc.identifier.citedreferenceMurray‐Taylor FM, Ho YY, Densupsoontorn N, Chang CL, Deckelbaum RJ, Seo T. n‐3, but not n‐6 lipid particle uptake requires cell surface anchoring. Biochem Biophys Res Commun. 2010; 5 ( 2 ): 135 ‐ 139.
dc.identifier.citedreferenceOliveira FL, Rumsey SC, Schlotzer E, Hansen I, Carpentier YA, Deckelbaum RJ. Triglyceride hydrolysis of soy oil vs fish oil emulsions. JPEN J Parenter Enteral Nutr. 1997; 21 ( 4 ): 224 ‐ 229.
dc.identifier.citedreferenceQi K, Seo T, Al‐Haideri M, Worgall TS, Vogel T, Carpentier YA, Deckelbaum RJ. Omega‐3 triglycerides modify blood clearance and tissue targeting pathways of lipid emulsions. Biochemistry. 2002; 41 ( 5 ): 3110 ‐ 3127.
dc.identifier.citedreferenceSato N, Deckelbaum RJ, Neeser G, Carpentier YA, Kinney JM. Hydrolysis of mixed lipid emulsions containing medium chain and long chain triacylglycerol with lipoprotein lipase in plasma‐like media. JPEN J Parenter Enteral Nutr. 1994; 18 ( 2 ): 112 ‐ 118.
dc.identifier.citedreferenceTon M, Chen C, Carpentier YA, Deckelbaum RJ. In vivo and in vitro properties of an intravenous lipid emulsion containing only medium chain and fish oil triglycerides. Clin Nutr. 2005; 24 ( 4 ): 492 ‐ 501.
dc.identifier.citedreferenceWilliams JJ, Mayurasakorn K, Vannucci et al. n‐3 fatty acid rich triglyceride emulsions are neuroprotective after cerebral hypoxic‐ischemic injury in neonatal mice. PLoS One. 2013; 8 ( 2 ): e56233.
dc.identifier.citedreferenceBerger MM, Delodder F, Liaudet L et al. Three short perioperative infusions of n‐3 PUFAs reduce systemic inflammation induced by cardiopulmonary bypass surgery: a randomized controlled trial. Am J Clin Nutr. 2013; 97 ( 2 ): 246 ‐ 254.
dc.identifier.citedreferenceCalder PC. Omega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. 2012; 75: 645 ‐ 662.
dc.identifier.citedreferenceCalder PC, Jensen GL, Koletzko BV, Singer P, Wanten GJA. Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions. Intensive Care Med. 2010; 36 ( 5 ): 735 ‐ 749.
dc.identifier.citedreferenceCarpentier YA. Are present fat emulsions appropriate? In: Wilmore DW, Carpentier YA, eds. Metabolic Support of the Critically Ill Patient. New York, NY: Springer‐Verlag; 1993; 157 ‐ 174.
dc.identifier.citedreferenceCarpentier YA, Hacquebard M, Portois L, Dupond IE, Deckelbaum RJ, Malaisse WJ. Rapid cellular enrichment of eicosapentaenoate after a single intravenous injection of a novel medium‐chain triacylglycerol:fish‐oil emulsion in humans. Am J Clin Nutr. 2010; 91 ( 4 ): 875 ‐ 882.
dc.identifier.citedreferenceCober MP, Killu G, Brattain A, Welch KB, Kunisaki SM, Teitelbaum DH. Intravenous fat emulsions reduction for patients with parenteral nutrition‐associated liver disease. J Pediatr. 2012; 160: 421 ‐ 427.
dc.identifier.citedreferenceGabe SM. Lipids and liver dysfunction in patients receiving parenteral nutrition, Curr Opin Clin Nutr Metab Care. 2013; 16 ( 2 ): 150 ‐ 155.
dc.identifier.citedreferenceHan YY, Lai SL, Ko WJ, Chou CH, Lai HS. Effects of fish oil on inflammatory modulation in surgical intensive care unit patients. Nutr Clin Pract. 2012; 27 ( 1 ): 91 ‐ 98.
dc.identifier.citedreferenceHolland DJ, Erne D, Kostner K et al. Acute elevation of triglycerides increases left ventricular contractility and alters ventricular‐vascular interaction. Am J Physiol Heart Circ Physiol. 2011; 301 ( 1 ): 123 ‐ 128.
dc.identifier.citedreferenceLi NN, Zhou Y, Qin XP et al. Does intravenous fish oil benefit patients post‐surgery? A meta‐analysis of randomised controlled trials. Clin Nutr. 2014; 33 ( 2 ): 226 ‐ 239.
dc.identifier.citedreferenceManzanares W, Dhaliwal R, Jurewitsch B, Stapleton RD, Jeejeebhoy KN, Heyland DK. Alternative lipid emulsions in the critically ill: a systematic review of the evidence. Intensive Care Med. 2013; 39 ( 10 ): 1683 ‐ 1694.
dc.identifier.citedreferenceManzanares W, Dhaliwal R, Jurewitsch B, Stapleton RD, Jeejeebhoy KN, Heyland DK. Parenteral fish oil lipid emulsions in the critically ill: a systematic review and meta‐analysis. JPEN J Parenter Enteral Nutr. 2014; 38 ( 1 ): 20 ‐ 28.
dc.identifier.citedreferencePittet YK, Berger MM, Pluess TT et al. Blunting the response to endotoxin in healthy subjects: effects of various doses of intravenous fish oil. Intensive Care Med. 2010; 36 ( 2 ): 289 ‐ 295.
dc.identifier.citedreferencePradelli L, Mayer K, Muscaritoli M, Heller AR. n‐3 fatty acid‐enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta‐analysis. Crit Care. 2012; 16 ( 5 ): R184.
dc.identifier.citedreferenceSimoens CM, Deckelbaum RJ, Massault JJ, Carpentier YA. Inclusion of 10% fish oil in mixed medium‐chain triacylglycerol‐long‐chain triacylglycerol emulsions increases plasma triacylglycerol clearance and induces rapid eicosapentaenoic acid (20:5n‐3) incorporation into blood cell phospholipids. Am J Clin Nutr. 2008; 88 ( 2 ): 282 ‐ 288.
dc.identifier.citedreferenceUmpierrez GE, Spiegelman R, Zhao V et al. A double‐blind, randomized clinical trial comparing soybean oil‐based versus olive oil‐based lipid emulsions in adult medical‐surgical intensive care units patients requiring parenteral nutrition. Crit Care Med. 2012; 40 ( 6 ): 1792 ‐ 1798.
dc.identifier.citedreferenceVanek VW, Seidner DL, Allen P et al. A.S.P.E.N. position paper: clinical role for alternative intravenous fat emulsions. Nutr Clin Pract. 2012; 27 ( 2 ): 150 ‐ 192.
dc.identifier.citedreferenceZhu X, Wu Y, Qiu Y, Jiang C, Ding Y. Effects of ω‐3 fish oil lipid emulsion combined with parenteral nutrition on patients undergoing liver transplantation, JPEN J Parenter Enteral Nutr. 2013; 37 ( 1 ): 68 ‐ 74.
dc.identifier.citedreferenceSchuberth O, Wretlind A. Intravenous infusion of fat emulsions, phosphatides and emulsifying agents: clinical and experimental studies. Acta Chir Scand. 1961; 278 ( suppl ): 1 ‐ 21.
dc.identifier.citedreferenceWretlind A. Development of fat emulsions: invited review. JPEN J Parenter Enteral Nutr. 1981; 5 ( 3 ): 230 ‐ 235.
dc.identifier.citedreferenceWretlind A. Parenteral nutrition symposium. Acta Chir Scand. 1964; 325 ( suppl ): 31.
dc.identifier.citedreferenceDibb M, Carlson G, Bradley A et al. Outcome on home parenteral nutrition: 33 years experience from a national centre. Gut. 2012; 61 ( suppl 2 ): A14.
dc.identifier.citedreferenceDibb M, Teubner A, Theis V, Shaffer J, Lal S. Review article: the management of long‐term parenteral nutrition. Aliment Pharmacol Ther. 2013; 37 ( 6 ): 587 ‐ 603.
dc.identifier.citedreferenceRoulet M, Frascarolo P, Pilet M, Chapuis G. Effects of intravenously infused fish oil on platelet fatty acid phospholipid composition and on platelet function in postoperative trauma. JPEN J Parenter Enteral Nutr. 1997; 21 ( 5 ): 296 ‐ 301.
dc.identifier.citedreferenceMorlion BJ, Torwesten E, Lessire H et al. The effect of parenteral fish oil on leukocyte membrane fatty acid composition and leukotriene‐synthetizing capacity in patients with postoperative trauma. Metabolism. 1996; 45 ( 1 ): 1208 ‐ 1213.
dc.identifier.citedreferenceRayyan M, Devlieger H, Jochum F, Allegaert K. Short‐term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium‐chain triglycerides, and fish oil: a randomized double‐blind study in preterm infants. JPEN J Parenter Enteral Nutr. 2012; 36 ( 1 suppl ): 81S ‐ 94S.
dc.identifier.citedreferenceGoulet O, Antébi H, Wolf C et al. A new intravenous fat emulsion containing soybean oil, medium‐chain triglycerides, olive oil, and fish oil: a single‐center, double‐blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2010; 34 ( 5 ): 485 ‐ 495.
dc.identifier.citedreferenceMertes N, Grimm H, Fürst P, Stehle P. Safety and efficacy of a new parenteral lipid emulsion (SMOFlipid) in surgical patients: a randomized, double‐blind, multicenter study. Ann Nutr Metab. 2006; 50 ( 3 ): 253 ‐ 259.
dc.identifier.citedreferenceAngus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013; 369: 840 ‐ 851.
dc.identifier.citedreferenceVanek VW, Seidner DL, Allen P et al. Novel nutrient task force, intravenous fat emulsions workgroup. American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. Nutr Clin Pract. 2012; 27: 150 ‐ 192.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jpen0768.pdf
Size:
184.8KB
Format:
PDF
View/Open
Name:
jpen0768-sup-0001.pdf
Size:
159.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.